2[1]Diamanti KE,Kouli CR,Bergiele AT,et al.A Survey of the polycystic ovary syndrome in the Greek island of Lesbox hormonal and metabolic profile[J].J Clin Endocrinol Metab.1999,84:4006-24011.
3[2]The Rotterdam ESHRE/ASRM-Sponsored PCOS Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycvstic ovary syndrome.Fertil Steril.2004,81(1):19-25.
4[3]Buqqs C,Rosenfield RL.Polvcvstic ovary syndrome in adolescence[J].Endocrlnol Metab Clin North Am.2005,34:677-705.
5[4]Fulqhesu AM,Ciampelli M,Belosi C,et al.A new ultrasound criterion for the diagnosis of polycystic ovary syndrome:The ovarian stroma/total area ratio[J].Fertil.2001,76(2):326-331.
6[5]Sheehan MT.Polycystic ovary syndrome diagnosis and management[J].Clin Med Res.2004,2(1):13-27.
7[6]Esienhardt S,Schwanzmann N,Henschel V,et al.Early effects of metformin in women with polycystic ovary syndrome:a prospective randomized,double-blind.Placebo-controlled trial.J Clin Endocrinol Metab.2006,91(3):946-952.
8[7]Piqny P,Jonard S,Robert Y,Dewailly D.Serum anti-Mullerian hormone as a surroqate for antral follicle count for definition of the polycystic ovary syndrome.J Clin Endocrinol Metab.2006,91(3):941-945.
9Weckstein LN, Kin Hampton RN, Jacobson A, et ai. Low- dose aspirin for occyte dommnation recipients with a thin endometrium:prospective,randomized study. Fertil Steril, 1997,68 (6) :927.
10Wada I,Hsu CC, Williams G,et al. The benefits of low -dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod, 1994,9 : 1954 - 1957.
